Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
Details for the panel are as follows:
Title: | “The Future of Influenza Vaccines” |
Date and Time: | Wednesday, June 5, 11:00 a.m. |
Moderator: | Bruce Gellin, M.D., M.P.H., President, Global Immunization, Sabin Vaccine Institute |
Panelists: | Mr. Trizzino Luciana Borio, Vice President, Technical Staff, In-Q-Tel Bruce D. Clark, Ph.D., Chief Executive Officer and President, Medicago, Inc. Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research (CBER) at Food and Drug Administration Gordon Naylor, President, Seqirus Paul Radspinner, President and Chief Executive Officer, FluGen Inc. |
About
For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.
Contacts:
Investors
Senior Manager, Investor & Public Relations
[email protected]
240-268-2000
[email protected]
443-213-0506